8 May 2024

Harmonic insights
Unveiling psychedelic mechanisms through music
by Rebecca Harding and Leor Roseman

MAPS Bulletin: Volume XXXIV Number 1 • 2024

Mandala Sound Waves; Image published under the Creative Commons Zero license

Music, a universal language with a profound capacity to evoke a variety of emotions, allows us to connect with the very essence of what it means to be human. For millennia, humans have used music to bring us together, to dance, to feel pleasure, to feel pain, to heal. As eloquently articulated by the legend Stevie Wonder: “Music is a world within itself; With a language we all understand; With an equal opportunity; For all to sing, dance and clap their hands.” These timeless sentiments resonate just as deeply in the discos of the 1970s as they do in bygone eras and those yet to come.

Music extends its influence far beyond the dance floors and concert halls, permeating even the scientific laboratories. In our clinical research, we use music as an essential tool, a vital ally, to help guide participants through their psychedelic journeys. Our curated music playlists serve as a ‘hidden therapist’ and serve as a crucial aspect of the therapeutic setting (Kaelen et al., 2018). Reflecting on their experiences, one participant observed: “Normally when I hear a piece of sad music, or happy music, I respond through choice, but under psilocybin I felt almost that I had no choice but to go with the music.” These words underscore the profound impact of music, which is amplified exponentially in psychedelic experiences as it helps us to tap into our deepest emotions.

The benefits of psychedelic therapy for mental health are undeniable. Clinical trials have revealed that their effectiveness expands across the spectrum of DSM-V classifications, from addiction to OCD. Although our grasp of how psychedelics alter the brain is yet nascent, we possess valuable insights into the neurobiology of these disorders. By leveraging our understanding of brain function and the alterations induced by psychedelics, we can decipher the intricate ways these substances modulate brain activity and the connectivity between different brain regions. 

By examining how we experience music, we can gain deeper insights into the complex interaction between this universal harmonic language and the psychopharmacological symphony induced by psychedelics.

 To enhance our understanding of psychedelic therapy, we can consider the core cognitive systems impacted by the disorders it can treat. At the heart of these systems is emotional processing, which plays a fundamental role in how we interpret and respond to the world. It equips us to react to joy and sorrow, and to manage our emotional climate. Inextricably interlinked with emotional processing is the concept of reward processing, which governs how we perceive pleasure. These processes share common neural pathways in the brain. The significance of these processes in psychiatric disorders is clear, with disturbances in these areas often being a hallmark of such conditions.

We also use music in the scientific method as an instrument to access and activate our emotion and pleasure centres; providing us with a means to explore how psychedelics may change our outlook on the world and reshape our understanding of psychiatry. In cognitive neuroscience, music serves as a unique lens through which we can explore the underlying mechanisms of mental health disorders and how effective treatments work. It offers us a dynamic insight into our emotional and reward systems—how we feel and what brings us pleasure. By examining how we experience music, we can gain deeper insights into the complex interaction between this universal harmonic language and the psychopharmacological symphony induced by psychedelics. 

At Imperial College London, we have conducted some of the most pioneering psychedelic clinical trials to date. One of our latest studies on major depressive disorder involved brain scans of participants before and 3 weeks after treatment with escitalopram, the most commonly prescribed SSRI (selective serotonin reuptake inhibitor) – a type of antidepressant, or psilocybin therapy (Carhart-Harris et al., 2021). During the scans, participants were asked to listen to the same contemplative, introspective piece of music, selected for its great emotional depth, to explore changes in emotional and neural responses to the music before and after treatment. By incorporating music into our scientific investigation, we can examine the profound impact of psychedelic therapy and gain insights into the emotional minds of our patients. 

Observing the brain through a psychological lens, we found stark differences between the two treatment conditions in the way music evoked emotion within patients. We measured the wide range of feelings elicited by music, which were broadly categorised into 9 emotions. Remarkably, after psilocybin therapy patients experienced trend increases in vitality during music listening, which is linked with feelings of joy and power. On the other hand, antidepressants caused decreases in these specific emotions, a finding that was statistically significant. This aligns with our initial hypothesis that the two treatments alter emotional processing in markedly different ways, underscoring the unique impact of psychedelic therapy on the emotional wellbeing of patients.

SSRIs have been widely used in psychiatry since the late ’80s and, like psychedelic therapy during the current renaissance, offered a disruptive addition to the psychopharmacological arsenal for addressing the mental health crisis. While SSRIs have saved countless lives globally, the reported side effects often present a barrier to effectively treating depression—not to mention their limited efficacy in only 40-60% of patients. One of the most commonly reported side effects is “emotional blunting,” where patients report a limited range of emotions they can experience, dampening the lows but also diminishing the highs, leaving them in a state of apathetic limbo. Conversely, psilocybin therapy, as our results indicate, may widen the emotional spectrum of the patient and rebalance their inner world toward a healthier landscape.

Beyond the emotional experiences of patients, differences in brain activity were observed between the two treatments. We examined how the brain processes ‘musical surprises’ during the song, which are linked to feelings of reward and pleasure—the ubiquitous ‘chills’ experienced when listening to music. Those who had received psilocybin therapy showed decreases in the activity of the ventromedial prefrontal cortex, whereas there was no change in those who had received escitalopram. This area, one of the higher-order processing areas in the brain, is linked to the executive control of emotion and is part of the default mode network. This network is shown to be active when the mind is focussed on the internal world and has been shown to be pathologically increased in depression. Therefore, a reduction in this area may indicate that psilocybin therapy causes a decrease in top-down control in emotional processing, thereby expanding the bandwidth of emotions experienced. Coupled with the finding that psilocybin therapy increases activation in sensory processing areas, this may be interpreted as a shift from excessively internal processing and rumination to a more external, sensory-driven mode which is characteristic of recovery from depression.

Perhaps this might explain the results we have observed out of the lab, beyond the clinical findings, which resonate with the human experience as a whole. As we know, music has the potential to cross linguistic and cultural barriers, but with the help of psychedelics, this capacity is heightened (Roseman et al., 2021). For instance, in our exploration of the relational dynamics of Israeli-Palestinian ayahuasca groups, participants reported experiencing a profound sense of recognition and connection with ‘the Other’ culture when listening to their music under the influence of ayahuasca. This connection induced feelings of awe in individuals, which is associated with the breaking down of mental barriers and the inclusion of what was previously excluded from mental structures. When these rigid frameworks dissolve, individuals are able to forge connections in surprising and rewarding ways. Therefore, perhaps this experience that we have captured during the surprising element of music harks to this component of human nature, and the feelings of connectedness through which we might be relieved of our unhealthy emotional processing. 

Also, our results echo the findings of previous studies that have revealed persisting changes in music-evoked emotion, outlasting the effects of the drug and providing a testament to the powerful implications of psychedelic therapy in improving our emotional processing. Previous studies in our lab revealed decreased music-evoked ‘sadness’ and increased music-evoked ‘peacefulness’ one day following psilocybin therapy (Shukuroglou et al., 2023). Likewise, that study observed changes in brain activity from before to after psilocybin therapy, with reductions in the connectivity of the nucleus accumbens, a region crucial to reward processing, with areas in the default mode network. This indicates a reduction in the activity of regions with a more top-down influence on how we understand the world around us and instead allows us to be more present with the incoming sensory information from the world around us.

Indeed, as with all scientific research, our research was not without its limitations. The emotion and reward one experiences during music listening is incredibly idiosyncratic; a reminder of the complexity and subjectivity inherent in the emotional lives of humans. The feelings that may arise when listening to music may be affected by a miscellany of factors, such as musical taste, cultural background, and personality traits. What might resonate as a chorus of angels to one person could be perceived as a nightmarish cacophony by others. As Humphrey Osmond articulately put it, ‘To fathom hell or soar angelic…’ – check out our playlist. 

Given that we only used one song for all participants, our ability to fully capture the nuances of music-evoked emotion and pleasure across the different treatments may be constrained. However, following rigorous scientific procedure, this afforded us control over the variables experienced by participants in the confines of the scanner. If only neuroimaging were cheaper and more convenient, and our capacity for inquiry boundless, our explorations into the mind would go deeper, and our playlists more extensive. Perhaps future research could explore more individualised playlists or a more diverse selection of musical genres to better accommodate for individual preferences and emotional responses. Nonetheless, despite these obstacles, we continue with gratitude to use music in our research, providing insights into the psychopharmacological and emotional changes spurred by these treatments and revealing where the harmony of healing resides.

Rebecca Harding

Rebecca Harding is a PhD student at the Clinical Psychopharmacology Unit at University College London. Her research uses fMRI to reveal the therapeutic potential of psychedelics. She completed her MSc at the Centre for Psychedelic Research at Imperial College London, looking at changes in music processing following psilocybin therapy compared to SSRI treatment for depression.

Leor Roseman

Leor Roseman is a Senior Lecturer and Psychedelic Researcher at the University of Exeter, where he teaches in the post-graduate certificate Psychedelics: Mind Medicine and Culture. He has previously worked at the Centre for Psychedelic Research, Imperial College London, under the mentorship of Prof. Robin Carhart-Harris and Prof. David Nutt, supporting the foundational work of a remerging research field. His interdisciplinary research covers neuroscience, psychology, phenomenology, anthropology and conflict resolution, using various research methods such as fMRI, quantitative, qualitative, microphenomenology, ethnographic, and participatory research. He is also the chair of RIPPLES, a new non-profit for psychedelic-assisted peacebuilding.